BridgeBio Oncology Therapeutics Inc.

BBOT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$408,741$31,518$963$1,698
Short-Term Investments$59,544$99,880$0$0
Receivables$226$1,077$0$0
Inventory$0$0$0$0
Other Curr. Assets$7,499$5,575$0$0
Total Curr. Assets$476,010$142,346$1,239$1,950
Property Plant & Equip (Net)$3,267$3,449$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$194,439$192,449
Tax Assets$0$0$0$0
Other NC Assets$5,516$5,458$0$25
Total NC Assets$8,783$8,907$194,439$192,474
Other Assets$0$0$0$0
Total Assets$484,793$151,253$195,678$194,424
Liabilities
Payables$3,650$2,197$1,784$0
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,489$2,740-$1,784$0
Total Curr. Liab.$35,712$27,251$1,871$188
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$349,221$5,520$5,520
Total NC Liab.$2,381$351,735$5,520$5,520
Other Liabilities$0$0$0$0
Cap. Leases$2,887$2,834$0$0
Total Liabilities$38,093$378,986$7,391$5,708
Equity
Pref Stock$0$0$0$0
Common Stock$8$0$194,439$192,450
Retained Earnings-$317,770-$273,013-$6,152-$3,733
AOCI$36$51$0$0
Other Equity$0$0$0$0
Total Equity$446,700-$227,733$188,287$188,717
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$484,793$151,253$195,678$194,424
Net Debt-$408,741-$31,518-$963-$1,698